Arena Pharma

Showing 1 posts of 1 posts found.

Arena’s obesity treatment lorcaserin rejected by FDA

October 25, 2010
Sales and Marketing Arena Pharma, Eisai, FDA, FDA complete response letter, lorcaserin, obesity

A new weight loss drug has been rejected by the FDA because of numerous concerns about side-effects and limited efficacy. …

The Gateway to Local Adoption Series

Latest content